Pfizer’s Marstacimab Wins In Phase III, But Caution On Market Position, Clotting Remain

 
• By Alaric DeArment
  
Pfizer announced Phase III results for marstacimab in hemophilia • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D